These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 2107078)

  • 1. Flecainide acetate in atrial flutter and fibrillation. The arrhythmogenic effects.
    Sihm I; Hansen FA; Rasmussen J; Pedersen AK; Thygesen K
    Eur Heart J; 1990 Feb; 11(2):145-8. PubMed ID: 2107078
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The value of class IC antiarrhythmic drugs for acute conversion of paroxysmal atrial fibrillation or flutter to sinus rhythm.
    Suttorp MJ; Kingma JH; Jessurun ER; Lie-A-Huen L; van Hemel NM; Lie KI
    J Am Coll Cardiol; 1990 Dec; 16(7):1722-7. PubMed ID: 2123909
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and utility of flecainide acetate in the routine care of patients with supraventricular tachyarrhythmias: results of a multicenter trial. The Flecainide Supraventricular Tachycardia Study Group.
    Hopson JR; Buxton AE; Rinkenberger RL; Nademanee K; Heilman JM; Kienzle MG
    Am J Cardiol; 1996 Jan; 77(3):72A-82A. PubMed ID: 8607395
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of flecainide acetate in the maintenance of sinus rhythm after electrical cardioversion of chronic atrial fibrillation or atrial flutter.
    Van Gelder IC; Crijns HJ; Van Gilst WH; Van Wijk LM; Hamer HP; Lie KI
    Am J Cardiol; 1989 Dec; 64(19):1317-21. PubMed ID: 2511744
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of flecainide on atrial and ventricular refractoriness and conduction in patients with normal left ventricle. Implications for possible antiarrhythmic and proarrhythmic mechanisms.
    Katritsis D; Rowland E; O'Nunain S; Shakespeare CF; Poloniecki J; Camm AJ
    Eur Heart J; 1995 Dec; 16(12):1930-5. PubMed ID: 8682029
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serial antiarrhythmic drug treatment to maintain sinus rhythm after electrical cardioversion for chronic atrial fibrillation or atrial flutter.
    Crijns HJ; Van Gelder IC; Van Gilst WH; Hillege H; Gosselink AM; Lie KI
    Am J Cardiol; 1991 Aug; 68(4):335-41. PubMed ID: 1907089
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of flecainide on termination of atrial flutter by rapid atrial pacing.
    Heldal M; Orning OM
    Eur Heart J; 1993 Mar; 14(3):421-4. PubMed ID: 8458365
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute pharmacologic conversion of atrial fibrillation and flutter: the role of flecainide, propafenone, and verapamil.
    Kingma JH; Suttorp MJ
    Am J Cardiol; 1992 Aug; 70(5):56A-60A; discussion 60A-61A. PubMed ID: 1510000
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the safety and efficacy of flecainide versus propafenone in hospital out-patients with symptomatic paroxysmal atrial fibrillation/flutter. The Flecainide AF French Study Group.
    Aliot E; Denjoy I
    Am J Cardiol; 1996 Jan; 77(3):66A-71A. PubMed ID: 8607394
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravenous flecainide versus verapamil for acute conversion of paroxysmal atrial fibrillation or flutter to sinus rhythm.
    Suttorp MJ; Kingma JH; Lie-A-Huen L; Mast EG
    Am J Cardiol; 1989 Mar; 63(11):693-6. PubMed ID: 2493733
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Short- and long-term efficacy and safety of flecainide acetate for supraventricular arrhythmias.
    Hohnloser SH; Zabel M
    Am J Cardiol; 1992 Aug; 70(5):3A-9A; discussion 9A-10A. PubMed ID: 1387287
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Flecainide therapy in patients treated for supraventricular tachycardia with near normal left ventricular function.
    Hughes MM; Trohman RG; Simmons TW; Castle LW; Wilkoff BL; Morant VA; Maloney JD
    Am Heart J; 1992 Feb; 123(2):408-12. PubMed ID: 1736577
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Flecainide-Induced Atrial Flutter With 1:1 Conduction Complicated by Ventricular Fibrillation After Electrical Cardioversion.
    Colangelo T; Johnson D; Ho R
    Tex Heart Inst J; 2021 Jun; 48(2):. PubMed ID: 34086956
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tachycardia due to atrial flutter with rapid 1:1 conduction following treatment of atrial fibrillation with flecainide.
    Taylor R; Gandhi MM; Lloyd G
    BMJ; 2010 Mar; 340():b4684. PubMed ID: 20219811
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The safety of flecainide treatment of atrial fibrillation: long-term incidence of sudden cardiac death and proarrhythmic events.
    Almroth H; Andersson T; Fengsrud E; Friberg L; Linde P; Rosenqvist M; Englund A
    J Intern Med; 2011 Sep; 270(3):281-90. PubMed ID: 21635583
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prospective comparison of flecainide versus quinidine for the treatment of paroxysmal atrial fibrillation/flutter. The Flecainide Multicenter Atrial Fibrillation Study Group.
    Naccarelli GV; Dorian P; Hohnloser SH; Coumel P
    Am J Cardiol; 1996 Jan; 77(3):53A-59A. PubMed ID: 8607392
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Flecainide in quinidine-resistant atrial fibrillation.
    Leclercq JF; Chouty F; Denjoy I; Coumel P; Slama R
    Am J Cardiol; 1992 Aug; 70(5):62A-65A. PubMed ID: 1510001
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Reduction of auricular fibrillation and tachycardia using intravenous flecainide].
    Cohen-Solal A; Juliard JM; Jaeger P; Farinotti P; Dahan M; Charlier P; Boujon B; Aumont MC
    Arch Mal Coeur Vaiss; 1987 Jul; 80(8):1290-6. PubMed ID: 3120666
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Evaluation of the anti-arrhythmia effect of intravenous flecainide in supraventricular tachyarrhythmias].
    Garre L; Alvarez A; Cianciulli T; Quiroga J; Califano J; Mautner B
    Arch Inst Cardiol Mex; 1989; 59(3):241-4. PubMed ID: 2506843
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravenous flecainide acetate for the clinical management of paroxysmal tachycardias.
    Nathan AW; Camm AJ; Bexton RS; Hellestrand KJ
    Clin Cardiol; 1987 May; 10(5):317-22. PubMed ID: 3109795
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.